Clinical trial
Efficacy and Safety of GHX02 in the Treatment of Acute Bronchitis: a Phase 2, Double-blind, Randomized Placebo-controlled Trial
NCT03310385 is registered in ClinicalTrials.gov with Daejeon University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy and Safety of GHX02 in the Treatment of Acute Bronchitis: a Phase 2, Double-blind, Randomized Placebo-controlled Trial
- Lead sponsor
- Daejeon University
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- March 18, 2019
- Completion date
- March 31, 2020
- Enrollment
- 150 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acute bronchitis